Morgan Stanley Adjusts Price Target on Criteo to $25 From $29, Maintains Equalweight Rating
Morgan Stanley lowered its price target on Criteo S.A. to $25 from $29 while keeping an Equalweight rating, according to the note cited in the article. The update was published Aug. 6, 2026. The change may affect investor expectations for the stock’s valuation.
How this was made
The 30-second read
Why it matters
For traders, the actionable element is the valuation signal from Morgan Stanley; however, without new operating data or guidance, it is more sentiment than catalyst.
Market read
A single analyst target cut can move short-term sentiment, but the unchanged rating and lack of new fundamentals keep the trading impact modest.
What to watch
The article body lacks the rationale behind the target change, so traders should not over-interpret it as a new earnings or guidance signal.
Background
The piece is a broker note summary stating a revised price target and unchanged rating for Criteo.
Ticker impact
Morgan Stanley cut its Criteo price target to $25 from $29 while keeping an Equalweight rating, signaling a valuation reset for CRTO.
Likely modest downside bias or underperformance versus peers until new company-specific catalysts emerge.
The only disclosed change is the price target reduction; the rating remains Equalweight, implying the broker sees no major fundamental deterioration beyond valuation.
Market effects
Limited read-through to ad-tech peers because the article provides no sector-wide catalyst, only a single-broker target change.
None indicated.
None indicated.
Counterpoint
Equalweight maintained suggests the target cut may reflect valuation methodology rather than a new negative operating outlook, limiting downside follow-through.
Key entities
- companyCriteo
Subject of the analyst price-target adjustment and rating maintenance.
- analyst_firmMorgan Stanley
Broker issuing the price target change to $25 from $29 and keeping Equalweight.
